These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37704955)

  • 1. Evaluation of allylestrenol for clinical pregnancies in patients treated with assisted reproductive techniques: a retrospective, propensity score matched, observational study.
    Yu Y; Yu T; Ding W; Xiu Y; Zhao M; Sun K; Zhang Q; Xu X
    BMC Pregnancy Childbirth; 2023 Sep; 23(1):660. PubMed ID: 37704955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.
    Nadarajah R; Rajesh H; Wong KY; Faisal F; Yu SL
    Singapore Med J; 2017 Jun; 58(6):294-297. PubMed ID: 27090598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone.
    Vidal A; Dhakal C; Werth N; Weiss JM; Lehnick D; Kohl Schwartz AS
    Front Endocrinol (Lausanne); 2023; 14():1128564. PubMed ID: 36992810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Dydrogesterone for Luteal Phase Support in Assisted Reproduction.
    Patki A
    Reprod Sci; 2024 Jan; 31(1):17-29. PubMed ID: 37488405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction.
    Griesinger G; Tournaye H; Macklon N; Petraglia F; Arck P; Blockeel C; van Amsterdam P; Pexman-Fieth C; Fauser BC
    Reprod Biomed Online; 2019 Feb; 38(2):249-259. PubMed ID: 30595525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
    Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
    Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study.
    Vuong LN; Pham TD; Le KTQ; Ly TT; Le HL; Nguyen DTN; Ho VNA; Dang VQ; Phung TH; Norman RJ; Mol BW; Ho TM
    Hum Reprod; 2021 Jun; 36(7):1821-1831. PubMed ID: 33930124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vaginal progesterone gel combined with oral dydrogesterone versus intramuscular progesterone for luteal support in hormone replacement therapy-frozen embryo transfer cycle.
    Xu H; Zhang XQ; Zhu XL; Weng HN; Xu LQ; Huang L; Liu FH
    J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102110. PubMed ID: 33727207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.
    Barbosa MW; Silva LR; Navarro PA; Ferriani RA; Nastri CO; Martins WP
    Ultrasound Obstet Gynecol; 2016 Aug; 48(2):161-70. PubMed ID: 26577241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN; Shirazee HH; Dam P; Goswami SK; Chatterjee R; Ghosh S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia.
    Ali AB; Ahmad MF; Kwang NB; Shan LP; Shafie NM; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):93-6. PubMed ID: 26910749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of vaginal administration of Crinone versus Utrogestan combined with oral dydrogesterone tablets for luteal support in PGT freeze-thaw embryo transfer cycles].
    Deng Y; Ou Z; Liang Y; Chen Z; Sun L
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1062-1066. PubMed ID: 34308857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients.
    Ozer G; Yuksel B; Yucel Cicek OS; Kahraman S
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102030. PubMed ID: 33271319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of different luteal support methods on clinical outcomes of frozen-thawed embryo transfer cycles].
    Yang R; Chi H; Chen L; Li R; Liu P; Qiao J
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(41):3256-8. PubMed ID: 25604229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination.
    Taş M; Uludag SZ; Aygen ME; Sahin Y
    Gynecol Endocrinol; 2020 Jan; 36(1):77-80. PubMed ID: 31464143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two different types of luteal support on pregnancy outcomes following antagonist fresh embryo transfer: a retrospective study.
    De M; Chen L; Zeng L; Wang Y; Yang R; Li R; Chi H
    BMC Pregnancy Childbirth; 2023 May; 23(1):316. PubMed ID: 37142960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study.
    Simon V; Robin G; Keller L; Ternynck C; Jonard S; Robin C; Decanter C; Plouvier P
    Front Endocrinol (Lausanne); 2022; 13():1039579. PubMed ID: 36619564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in
    Yang DZ; Griesinger G; Wang W; Gong F; Liang X; Zhang H; Sun Y; Kahler E; Pexman-Fieth C; Olofsson JI; Tournaye H; Chen ZJ
    Gynecol Endocrinol; 2020 Feb; 36(2):175-183. PubMed ID: 31397179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.